Mesalamine
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Mesalamine is a prescription medication in delayed-release capsule form (400 mg) used to treat inflammatory bowel diseases like ulcerative colitis and Crohn's disease. It belongs to the aminosalicylate class and works by reducing inflammation in the colon. Manufactured by Teva Pharmaceuticals USA, Inc., it's available as a generic under ANDA 207873. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Mesalamine
Access the FDA dataset for Mesalamine โ ANDA 203308 submitted by Mylan Institutional LLC
Modified Mar 24, 2026